GHK-Cu (Copper Peptide)
GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) with a strong affinity for copper ions. It is present in human plasma, saliva, and urine, and its concentration declines with age. GHK-Cu has broad regenerative effects including stimulating collagen and elastin synthesis, promoting wound healing, reducing inflammation, and supporting hair follicle growth. It is used both topically for skin rejuvenation and systemically via injection for tissue remodeling.
FormBlends Peptide Context
Reviewed May 14, 2026Ghk Cu peptide guide should help a reader move from broad search interest to specific verification. When the topic touches peptide therapy, the important details are evidence quality, clinical fit, contraindications, pricing, pharmacy transparency, and follow-up support. Use this page to decide what to ask next rather than treating it as personal medical advice.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
Clinical decision snapshot
GHK-Cu authority snapshot
GHK-Cu is evaluated by mechanism, evidence quality, regulatory status, practical access, and safety questions a licensed clinician would need to review before use.
Evidence signal
Meaningful evidence with limits
Regulatory reality
Reinstated for compounding (Feb 2026)
Safety screen
Mild skin irritation with topical use (rare), Injection site redness, Mild stomach discomfort with systemic use should be reviewed in context.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
Decision path
What is the supervised-review path for GHK-Cu?
GHK-Cu should be evaluated by evidence quality, safety status, source quality, dosing context, and whether the goal fits a legitimate clinical pathway. This page is a research and decision aid, not a self-prescribing guide.
- Peptide
- GHK-Cu
- Category
- Skin and Healing
- Evidence
- Meaningful evidence with limits
- FDA status
- Not FDA approved
Step 1
Check evidence level
GHK-Cu has a solid research base spanning decades. Dr. Loren Pickart published extensively on copper peptides starting in the 1980s, and there are multiple human studies showing wound healing and skin rejuvenation effects. The evidence is moderate because most studies are small and many focus on topical rather than injectable use.
Review evidenceStep 2
Screen safety context
Mild skin irritation with topical use (rare), Injection site redness, Mild stomach discomfort with systemic use should be discussed in light of history, dose, and source.
Check side effectsStep 3
Confirm access route
If FormBlends offers access, review the product page and provider pathway before deciding.
Review product accessSkin and repair hub
GHK-Cu content should connect skin, wound repair, and gene-expression evidence carefully
GHK-Cu has real research history and a huge cosmetic halo. The stronger page does not treat it as a magic anti-aging peptide. It explains copper binding, collagen support, wound-healing signals, topical versus injectable context, and why cosmetic claims need different evidence than medical claims.
Decision question for GHK-Cu
Is the reader comparing a skin-health product, a recovery peptide, or a medical wound problem that needs care first?
Peptide evidence layer
Evidence read
Useful GHK-Cu content should discuss the long research history, collagen and extracellular-matrix context, copper peptide biology, topical formulation issues, and the difference between lab findings, cosmetic outcomes, and clinical medical claims.
Safety watch
Readers should be routed away from self-treating open wounds, infections, ulcers, severe acne, unexplained hair loss, or skin lesions that need professional diagnosis.
Conversion fit
The conversion path should clarify whether the goal is topical skin support, recovery context, or a clinical skin concern that needs evaluation before any product discussion.
Last updated: April 3, 2026
Typical Dosage
Topical: serums containing 1-2% GHK-Cu applied once or twice daily. Injectable: 1-2 mg subcutaneously, 3-5 times per week.
Administration
Topical cream or serum, Subcutaneous injection
Typical Cost
$40-100/month for topical products. $100-200/month for injectable formulations.
FDA Status
Not FDA Approved
Half-Life
Short, estimated at 1-2 hours for injectable. Topical formulations provide sustained local delivery.
Onset of Action
Topical skin improvements visible in 4-8 weeks. Injectable effects on wound healing may show within 1-2 weeks.
Bioavailability
Topical penetration varies by formulation. Injectable provides systemic distribution. Not orally bioavailable.
About GHK-Cu
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide naturally found in human plasma, saliva, and urine. Its molecular weight is 403.93 Da (with copper). CAS number: 49557-75-7. The peptide was first isolated in 1973 by Loren Pickart, who discovered it as a factor in human plasma that promoted liver cell growth (PMID: 4731367).
The "Cu" in GHK-Cu refers to a copper ion chelated within the peptide's structure. This copper binding is central to how the compound works. GHK-Cu delivers bioavailable copper to cells, activating copper-dependent enzymes like superoxide dismutase (an antioxidant) and lysyl oxidase (required for collagen cross-linking). Without adequate copper delivery, these enzymes can't function properly, and tissue repair slows down.
A 2015 review in BioMed Research International (PMID: 25866797) mapped the gene expression changes triggered by GHK-Cu and found it modulates over 4,000 human genes. That's an unusually broad effect for a simple tripeptide. The affected pathways include wound healing, collagen synthesis, anti-inflammation, antioxidant defense, and stem cell recruitment.
The human evidence for GHK-Cu is better than many peptides, though most studies focus on topical use. A 2004 study in the Journal of Surgical Research (PMID: 15172218) tested GHK-Cu cream on surgical wounds and found significantly faster healing compared to controls. Multiple cosmetic studies have shown improvements in skin thickness, elasticity, and wrinkle depth with topical GHK-Cu products.
Injectable GHK-Cu is a newer application. The theory is that systemic delivery provides copper peptide access to deeper tissues that topical can't reach. Practitioners commonly use 1-2 mg injected subcutaneously daily or every other day, typically as part of anti-aging or recovery protocols.
Natural GHK-Cu levels in the body decline significantly with age. Plasma concentrations drop roughly 60% between age 20 and 60. This decline correlates with reduced wound healing capacity, thinner skin, and slower tissue repair. The idea behind supplementation is straightforward: restore something the body used to have more of.
GHK-Cu is frequently stacked with BPC-157 for recovery protocols and with other anti-aging peptides (epithalon, NAD+) for longevity-focused regimens. The topical form is available without prescription as a cosmetic ingredient, while the injectable form requires a compounding pharmacy.
Store lyophilized GHK-Cu at -20C. Reconstitute with bacteriostatic water, swirling gently. Use within 21 days of reconstitution when stored at 2-8C.
How GHK-Cu Works
GHK-Cu activates tissue remodeling by upregulating genes involved in collagen synthesis, glycosaminoglycan production, and antioxidant defense. The copper ion it carries is essential for the function of lysyl oxidase, an enzyme required for collagen and elastin crosslinking. GHK-Cu also stimulates the production of decorin, which regulates collagen fibril assembly, and it attracts immune cells to wound sites while simultaneously reducing excessive inflammation and fibrosis.
Receptor targets:
Benefits
- Stimulates collagen and elastin synthesis in skin
- Accelerates wound healing and reduces scarring
- Promotes hair follicle growth and increases hair thickness
- Reduces fine lines and improves skin elasticity
- Provides antioxidant protection against free radical damage
- Reduces chronic inflammation in tissues
- Supports tissue remodeling after injury or surgery
What Does the Research Say?
GHK-Cu has a solid research base spanning decades. Dr. Loren Pickart published extensively on copper peptides starting in the 1980s, and there are multiple human studies showing wound healing and skin rejuvenation effects. The evidence is moderate because most studies are small and many focus on topical rather than injectable use.
Human plasma factor that promotes connective tissue growth
Biochemical and Biophysical Research Communications, 1973 · DOI · PubMed
Original discovery of GHK as a human plasma factor that stimulates liver cell growth and tissue repair
Improved wound healing with copper peptide GHK-Cu
Journal of Surgical Research, 2004 · PubMed
GHK-Cu cream applied to surgical wounds significantly accelerated healing compared to controls in a human trial
PubMed evidence trail
Research sources used to frame this page
For GHK-Cu, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Potential Side Effects
- Mild skin irritation with topical use (rare)
- Injection site redness
- Mild stomach discomfort with systemic use
- Temporary skin dryness during initial topical use
Drug Interactions
| Compound | Interaction | Severity |
|---|---|---|
| Other copper supplements | GHK-Cu provides bioavailable copper. Taking additional copper supplements could lead to copper excess, though this is unlikely at standard GHK-Cu doses. | minor |
Who Is GHK-Cu For?
Women
Popular for anti-aging skin applications. No sex-specific safety concerns identified. Often used alongside HRT for skin quality improvements during menopause.
Adults Over 50
Natural GHK-Cu levels decline with age (plasma levels drop roughly 60% between age 20 and 60). Supplementation may help restore age-related decline in tissue repair capacity.
Athletes
Not on WADA's prohibited list. Used for wound healing and recovery rather than performance enhancement.
Regulatory Status
FDA Approved
No
Compounding Legal
Yes
2026 HHS Status
Reinstated for compounding (Feb 2026)
GHK-Cu is available both as an injectable peptide through compounding pharmacies and as a topical ingredient in cosmetic products. The injectable form was reinstated for compounding in February 2026.
Last verified: 2026-04-06
Stacking Options
GHK-Cu is commonly stacked with the following peptides for enhanced results:
Conditions Addressed
Get GHK-Cu from FormBlends
Pharmaceutical-grade ghk-cu with free physician consultation.
View Product DetailsFind a GHK-Cu Clinic Near You
Browse peptide therapy clinics in your area that offer ghk-cu treatments.
Find Peptide Clinics